Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ADALIMUMAB Cause Wrong technique in drug usage process? 1,571 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 1,571 reports of Wrong technique in drug usage process have been filed in association with ADALIMUMAB (YUSIMRY). This represents 0.3% of all adverse event reports for ADALIMUMAB.

1,571
Reports of Wrong technique in drug usage process with ADALIMUMAB
0.3%
of all ADALIMUMAB reports
1
Deaths
49
Hospitalizations

How Dangerous Is Wrong technique in drug usage process From ADALIMUMAB?

Of the 1,571 reports, 1 (0.1%) resulted in death, 49 (3.1%) required hospitalization.

Is Wrong technique in drug usage process Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ADALIMUMAB. However, 1,571 reports have been filed with the FAERS database.

What Other Side Effects Does ADALIMUMAB Cause?

Drug ineffective (71,926) Pain (37,514) Arthralgia (35,592) Rheumatoid arthritis (29,817) Fatigue (29,420) Injection site pain (28,679) Headache (19,891) Nausea (19,299) Rash (18,690) Pain in extremity (18,319)

What Other Drugs Cause Wrong technique in drug usage process?

FENTANYL (832) HUMIRA (793) ARIPIPRAZOLE (584) BUPRENORPHINE\NALOXONE (527) DAYTRANA (376) ETHINYL ESTRADIOL\NORELGESTROMIN (349) ONABOTULINUMTOXINA (344) BOTOX COSMETIC (307) ETANERCEPT (285) METHYLPHENIDATE (284)

Which ADALIMUMAB Alternatives Have Lower Wrong technique in drug usage process Risk?

ADALIMUMAB vs ADALIMUMAB-AACF ADALIMUMAB vs ADALIMUMAB-AATY ADALIMUMAB vs ADALIMUMAB-ADAZ ADALIMUMAB vs ADALIMUMAB-ADBM ADALIMUMAB vs ADALIMUMAB-AFZB

Related Pages

ADALIMUMAB Full Profile All Wrong technique in drug usage process Reports All Drugs Causing Wrong technique in drug usage process ADALIMUMAB Demographics